
Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA ... Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.55 | -15.3465346535 | 10.1 | 10.225 | 8.39 | 14110 | 9.08915911 | CS |
4 | -4.65 | -35.2272727273 | 13.2 | 13.4468 | 8.39 | 20468 | 10.9012273 | CS |
12 | -22.41 | -72.3837209302 | 30.96 | 34.99 | 7.7 | 116356 | 16.28050467 | CS |
26 | 6.675 | 356 | 1.875 | 36 | 1.44 | 886009 | 6.84310871 | CS |
52 | 5.45 | 175.806451613 | 3.1 | 36 | 1.44 | 974999 | 4.64608245 | CS |
156 | 7.6995 | 905.291005291 | 0.8505 | 36 | 0.423 | 1952823 | 1.8346747 | CS |
260 | -2.1 | -19.7183098592 | 10.65 | 36 | 0.423 | 1852805 | 2.58231127 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales